Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David N Taylor

Showing results (11-20 of 50) with videos related to

Pageof 5
Sort By:
Journal of Travel Medicine|August 29, 2020
What will travel medicine look like in the COVID-19 pandemic era?David R Shlim, Bradley A Connor, David N Taylor
Journal of Pediatric Gastroenterology and Nutrition|October 24, 2002
Growth slowing after acute Helicobacter pylori infection is age-dependentDouglas J Passaro, David N Taylor, Robert H Gilman, et al.
Antimicrobial Agents and Chemotherapy|December 19, 2007
Systemic pharmacokinetics of rifaximin in volunteers with shigellosisDavid N Taylor, Robin McKenzie, Anna Durbin, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 6, 2006
Rifaximin, a nonabsorbed oral antibiotic, prevents shigellosis after experimental challengeDavid N Taylor, Robin McKenzie, Anna Durbin, et al.
Vaccine|January 22, 2008
Serum IgG antibody response to the protective antigen (PA) of Bacillus anthracis induced by anthrax vaccine adsorbed (AVA) among U.S. military personnelDarrell E Singer, Rachel Schneerson, Christian T Bautista, et al.
Viruses|September 23, 2022
The Rise and Fall of SARS-CoV-2 Variants and Ongoing Diversification of OmicronTanner Wiegand, Artem Nemudryi, Anna Nemudraia, et al.
Journal of Travel Medicine|January 24, 2007
Rifaximin treatment of pathogen-negative travelers' diarrheaHerbert L DuPont, Robert Haake, David N Taylor, et al.
The Journal of Pediatrics|February 28, 2002
Effects of nutritional status on diarrhea in Peruvian childrenWilliam Checkley, Robert H Gilman, Robert E Black, et al.
Vaccine|May 21, 2011
Induction of a potent immune response in the elderly using the TLR-5 agonist, flagellin, with a recombinant hemagglutinin influenza-flagellin fusion vaccine (VAX125, STF2.HA1 SI)David N Taylor, John J Treanor, Cynthia Strout, et al.
Vaccine|June 27, 2006
Immunogenicity and tolerance of ascending doses of a recombinant protective antigen (rPA102) anthrax vaccine: a randomized, double-blinded, controlled, multicenter trialGeoffrey J Gorse, Wendy Keitel, Harry Keyserling, et al.
Pageof 5

Showing results (11-20 of 50) with videos related to

Sort By:
Pageof 5
Journal of Travel Medicine|August 29, 2020
What will travel medicine look like in the COVID-19 pandemic era?David R Shlim, Bradley A Connor, David N Taylor
Journal of Pediatric Gastroenterology and Nutrition|October 24, 2002
Growth slowing after acute Helicobacter pylori infection is age-dependentDouglas J Passaro, David N Taylor, Robert H Gilman, et al.
Antimicrobial Agents and Chemotherapy|December 19, 2007
Systemic pharmacokinetics of rifaximin in volunteers with shigellosisDavid N Taylor, Robin McKenzie, Anna Durbin, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 6, 2006
Rifaximin, a nonabsorbed oral antibiotic, prevents shigellosis after experimental challengeDavid N Taylor, Robin McKenzie, Anna Durbin, et al.
Vaccine|January 22, 2008
Serum IgG antibody response to the protective antigen (PA) of Bacillus anthracis induced by anthrax vaccine adsorbed (AVA) among U.S. military personnelDarrell E Singer, Rachel Schneerson, Christian T Bautista, et al.
Viruses|September 23, 2022
The Rise and Fall of SARS-CoV-2 Variants and Ongoing Diversification of OmicronTanner Wiegand, Artem Nemudryi, Anna Nemudraia, et al.
Journal of Travel Medicine|January 24, 2007
Rifaximin treatment of pathogen-negative travelers' diarrheaHerbert L DuPont, Robert Haake, David N Taylor, et al.
The Journal of Pediatrics|February 28, 2002
Effects of nutritional status on diarrhea in Peruvian childrenWilliam Checkley, Robert H Gilman, Robert E Black, et al.
Vaccine|May 21, 2011
Induction of a potent immune response in the elderly using the TLR-5 agonist, flagellin, with a recombinant hemagglutinin influenza-flagellin fusion vaccine (VAX125, STF2.HA1 SI)David N Taylor, John J Treanor, Cynthia Strout, et al.
Vaccine|June 27, 2006
Immunogenicity and tolerance of ascending doses of a recombinant protective antigen (rPA102) anthrax vaccine: a randomized, double-blinded, controlled, multicenter trialGeoffrey J Gorse, Wendy Keitel, Harry Keyserling, et al.
Pageof 5